A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

OsteoCentric Technologies Introduces THEIR Mechanical Integration UnifiMI Technology to the $7.6b Spinal Fusion Market

Mechanical Integration, the first new method to secure implants to bone since the introduction of osseointegration in the 1970s, is designed to address implant instability in normal and compromised bone

OsteoCentric Technologies, the pioneer of Mechanical Integration, announces the execution of a private label agreement with Altus Spine which will propel their subsidiary, OsteoCentric Spine, LLC, into the pedicle screw fixation space.

The agreement will allow OsteoCentric to marry its Mechanical Integration technology platform, UnifiMITM, to an existing FDA-cleared system.

OsteoCentric Technologies plans to enter the spinal fusion market segment in Q2 2022, and introduce its revolutionary minimally invasive method of instantly securing Pedicle Fastener implants to bone.

This new UnifiMI product launch comes on the heels of announcing the company’s acquisition of the Integrity-SITM Fusion System from Lincotek/Mayo Clinic in October 2021. “Our expansion into spine establishes an additional cornerstone for us as we continue to broaden the Mechanical Integration platform across the spine, sports, total joint reconstruction, extremities, oncology, trauma, veterinary, and dental segments. Our successful conversion of KOL surgeons at dozens of leading Trauma Teaching Centers provides a clear roadmap to achieve the same disruption in the $7.6B US spinal fusion market segment[1],” says Gavin Sontag, Chief Marketing Officer at OsteoCentric.

UnifiMI‘s clinical value, user demand, and market penetration potential have been proven over the last 24 months. With the announcement of this agreement, OsteoCentric plans to prove how quickly and efficiently a standard interference fit implant can be upgraded to a Mechanically Integrated version in the spine space.

“There have been no significant design changes to our method for securing pedicle screws to bone in the last several decades,” says Dr. Kade Huntsman, MD, a board-certified orthopedic surgeon specializing in the treatment of the spine and practicing at St. Mark’s Hospital in Salt Lake City, Utah. “I can attest that the failure of the pedicle screw-bone interface is a common occurrence. Once launched, OsteoCentric’s new method of fixating pedicle screws will be a game-changer that addresses these failures and completely disrupts the market. I am confident it will soon become the new standard of care.”

Additionally, OsteoCentric is pleased to be listed by MedTech Outlook as a Top 10 Orthopedic Solution Provider. The list includes companies that make a significant contribution to the healthcare sector, as well as those that address challenges in treating patients suffering from orthopedic issues.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.
“We are excited to present the first look at the safety and clinical activity of ELVN-001, which we believe supports the potential for ELVN-001 to address the limitations of the available active-site TKIs,” said Helen Collins, M.D., Chief Medical Officer of Enliven. “Across a wide dose range, ELVN-001 demonstrated activity in a heavily pre-treated patient population that includes post-asciminib patients, with a preliminary safety profile consistent with its highly selective design. Not only did all evaluable patients have improved or stable BCR::ABL1 transcript levels, but, importantly, 89% of all patients enrolled remain on study. We believe the initial data demonstrate the potential clinical utility of ELVN-001 for all types of patients, including those that are earlier in the treatment paradigm.”
The partnership is with Health-HavenRx ™, an online pharmacy platform. This partnership enables a new, convenient channel for patients to access POGO Automatic by using their health insurance on Intuity Medical’s e-commerce website at www.GoodtoPogo.com.

By using this website you agree to accept Medical Device News Magazine Privacy Policy